Skinade® has launched an injection support programme, exclusively designed for medical professionals providing dermal filler and botulinum toxin-type aesthetic injectable treatments.
Designed to be integrated into in-clinic aesthetic injectable protocols to help patients prepare and recover from injectable treatments, SkinadeMD® INsupport™ enhances results and mitigates bruising and swelling, increasing patient satisfaction and retention.
The three-component protocol covers 10 days, pre and post-treatment. The programme integrates liquid sachets, capsules, and a sublingual spray, enabling the active ingredients to be consumed with optimal efficacy to improve results and mitigate treatment impacts.
“Ever-increasing numbers of medical practitioners now stock and recommend our Skinade® brand,” said Skinade® chief executive Piers Raper. “SkinadeMD® INsupport™ injection support programme for injection perfection is the second addition to our important SkinadeMD® product line that is only available to medical professionals.
“Bruising and swelling from injectable treatments creates feelings of self-consciousness and INsupport™ targets these from the inside, helping patients return to normal social activities sooner whilst enhancing treatment results. Our team is very excited and proud to be launching this innovative product to the important injectable space.”
SkinadeMD® INsupport™ is available now via selected Skinade® medical stockist practitioners, shipping on December 1, 2022.
